Nucynta

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Tapentadol (Nucynta) is a centrally acting opioid analgesic prescribed for the treatment of moderate to severe acute pain. Its… Expand
Is this relevant?
2012
2012
Tapentadol is a DEA schedule II opioid medication with a safety profile, duration of action, frequency of dosing, and analgesic… Expand
Is this relevant?
2011
2011
New formulation: Tapentadol extended release tablets were FDA approved for the management of moderate-to-severe chronic… Expand
Is this relevant?
2009
2009
  • The Medical letter on drugs and therapeutics
  • 2009
The FDA has approved tapentadol hydrochloride (Nucynta--Ortho-McNeil Janssen) for oral treatment of moderate to severe acute pain… Expand
Is this relevant?